Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The development of targeted cancer therapies like Lenvatinib is a testament to advancements in medicinal chemistry and pharmaceutical manufacturing. At the heart of Lenvatinib's synthesis lies Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate (CAS: 205448-66-4), a precisely engineered chemical intermediate that provides the core quinoline structure essential for the drug's pharmacological activity. Understanding the properties and reliable sourcing of this compound is vital for any entity involved in Lenvatinib production.
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate is a derivative of quinoline, featuring a carboxylate ester group and chlorine and methoxy substituents. These functional groups are strategically placed to facilitate subsequent chemical transformations in the multi-step synthesis of Lenvatinib. Its consistent availability and high purity, typically above 98.0% (HPLC), as supplied by NINGBO INNO PHARMCHEM CO.,LTD., are critical for ensuring the efficiency and reliability of the entire manufacturing process. As a leading pharmaceutical intermediate manufacturer, we pride ourselves on delivering compounds that meet the exacting standards of the pharmaceutical industry.
NINGBO INNO PHARMCHEM CO.,LTD. operates as a key lenvatinib intermediate supplier in China, dedicated to providing the global pharmaceutical market with essential building blocks. Our expertise encompasses not only the synthesis but also the stringent quality control necessary for these critical compounds. When you choose to buy methyl 4-chloro-7-methoxyquinoline-6-carboxylate from us, you are securing a product that is manufactured with precision and adherence to industry best practices. This dedication ensures that our clients receive a dependable component for their API production.
The role of Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate extends beyond its direct use in synthesis; it also serves as a vital reference standard. This means its purity and characterization are crucial for analytical testing, helping to identify and quantify potential impurities in the final Lenvatinib product. This dual function highlights the compound's fundamental importance in maintaining the quality assurance of cancer medications. Our commitment to providing a high purity lenvatinib intermediate supports our clients in meeting these crucial regulatory and quality benchmarks.
We are committed to advancing pharmaceutical manufacturing by providing reliable access to essential chemical components. For companies seeking a trusted source for their Lenvatinib intermediate needs, NINGBO INNO PHARMCHEM CO.,LTD. offers unparalleled quality and service. Our focus on chemical integrity ensures that the backbone of Lenvatinib, Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate, is of the highest standard, contributing to the development and availability of critical cancer treatments worldwide.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
